A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study Of The Pharmacokinetics And Pharmacodynamics Of Regn3918, A Human Antibody Against Complement Factor C5, In Healthy VolunteersJonathan Weyne, Yan Ni,Richard Delgizzi,Stephen Godin,Lori Morton,Srinivasa Prasad,Andrew J. Rankin, Melissa Simek-Lemos,Ming-Dauh Wang,Ronda Rippley,Olivier HarariBLOOD（2018）引用 11|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
